Armata Pharmaceuticals, Inc. (ARMP) stock
Close on Nov 17, 2026Market cap $98.90MP/E –Yield –
Earnings
Armata Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Armata Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 24, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026after the close | $3.20M | +166.7% | -$0.24 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 12, 2026during market hours | $2.50M | – | -$0.27 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 13, 2026during market hours | $800.00K | +60.0% | -$3.16 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 25, 2026during market hours | $1.10M | -8.3% | -$3.42 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025during market hours | $1.20M | -60.0% | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025during market hours | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 14, 2025during market hours | $500.00K | -50.0% | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 21, 2025after the close | $1.20M | -20.0% | -$0.23 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024during market hours | $3.00M | +150.0% | -$0.15 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024during market hours | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024during market hours | $1.00M | +25.0% | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 21, 2024during market hours | $1.50M | +36.4% | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023during market hours | $1.20M | -7.7% | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023before the open | $1.00M | -47.4% | -$0.17 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 12, 2023after the close | $800.00K | – | -$0.40 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 16, 2023during market hours | $1.10M | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022during market hours | $1.30M | – | -$0.24 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022during market hours | $1.90M | – | -$0.26 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 13, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 14, 2021during market hours | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 19, 2020during market hours | – | – | – | Filing |
| Q2 FY2018ended Jun 30, 2018 | Aug 9, 2018during market hours | – | – | – | Filing |
| Q1 FY2018ended Mar 31, 2018 | May 15, 2018during market hours | – | – | – | Filing |
| Q4 FY2017ended Dec 31, 2017 | Mar 14, 2018during market hours | – | – | – | Filing |
| Q3 FY2017ended Sep 30, 2017 | Nov 14, 2017during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Armata Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Armata Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Armata Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Update
- Results
- Update
- Update
- News
- Results
- Update
- Update
- Results
- Update
- Update
- Update
- Results
See a number that looks wrong?